Scarica l'app Stockscreener
29.44
9.14%
-2.96
Dopo l'orario di chiusura:
29.47
0.03
+0.10%
Precedente Chiudi:
$32.40
Aprire:
$32.29
Volume 24 ore:
4.25M
Relative Volume:
1.81
Capitalizzazione di mercato:
$2.83B
Reddito:
$47.30M
Utile/perdita netta:
$-225.97M
Rapporto P/E:
-12.53
EPS:
-2.35
Flusso di cassa netto:
$-188.86M
1 W Prestazione:
-28.18%
1M Prestazione:
-8.97%
6M Prestazione:
-1.08%
1 anno Prestazione:
+1.52%
Intervallo 1D:
$29.15
$32.64
Intervallo di 1 settimana:
$29.00
$41.42
Portata 52W:
$22.71
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Nome
Scholar Rock Holding Corp
Settore
Industria
Telefono
857-259-3860
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta SRRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
29.44 | 3.07B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Iniziato | BofA Securities | Buy |
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-15 | Iniziato | Leerink Partners | Outperform |
| 2025-08-21 | Ripresa | Jefferies | Buy |
| 2025-07-30 | Ripresa | Raymond James | Strong Buy |
| 2025-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Reiterato | H.C. Wainwright | Buy |
| 2024-10-07 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-28 | Iniziato | Raymond James | Strong Buy |
| 2023-10-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-04-03 | Ripresa | Piper Sandler | Overweight |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-07-12 | Iniziato | Truist | Buy |
| 2022-03-23 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-22 | Downgrade | Jefferies | Buy → Hold |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | Credit Suisse | Outperform |
| 2021-01-06 | Iniziato | JP Morgan | Overweight |
| 2020-03-12 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Scholar Rock Holding Corp Borsa (SRRK) Ultime notizie
Scholar Rock (NASDAQ:SRRK) Shares Down 6.4%Should You Sell? - MarketBeat
How Scholar Rock Holding Corporation stock performs after earningsMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Candlestick signals on Scholar Rock Holding Corporation stock todayQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Scholar Rock stock falls as FDA issues OAI for Catalent site - Investing.com Nigeria
Why Is Scholar Rock Stock Trading Lower On Monday? - Sahm
FDA issues official action indicated status for Catalent Indiana facility owned by Novo Nordisk - Investing.com UK
FDA issues official action indicated status for Catalent Indiana facility owned by Novo Nordisk By Investing.com - Investing.com South Africa
Scholar Rock (SRRK) Valuation in Focus as Analyst Initiation and Insider Buying Signal Renewed Optimism - simplywall.st
Scholar Rock (SRRK) Faces Regulatory Challenges Impacting Stock - GuruFocus
Why Scholar Rock Stock Got Socked on Monday - The Motley Fool
Scholar Rock (SRRK) Sees Significant Stock Decline - GuruFocus
Scholar Rock (NASDAQ:SRRK) Shares Gap DownWhat's Next? - MarketBeat
Scholar Rock Sees Unusually Large Options Volume (NASDAQ:SRRK) - MarketBeat
Scholar Rock stock falls after FDA flags issues at manufacturing facility - Investing.com Nigeria
Scholar Rock stock falls after FDA flags issues at manufacturing facility By Investing.com - Investing.com South Africa
Scholar Rock (SRRK) Shares Plummet Amid Market Volatility - GuruFocus
Scholar Rock says FDA determined Catalent Indiana inspection classification as OAI - MarketScreener
Scholar Rock Says FDA Determined Catalent Indiana Inspection Classification As OAI - TradingView
Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Multi factor analysis applied to Scholar Rock Holding Corporation - newser.com
Why Scholar Rock Stock Raced 6% Higher Today - AOL.com
Why analysts remain bullish on Scholar Rock Holding Corporation stockTake Profit & Fast Entry High Yield Tips - newser.com
Is Scholar Rock Holding Corporation a good long term investmentGap Fill Strategies & Exceptional Profit Trading - earlytimes.in
A Key Insider Purchase At Scholar RockInsider Weekends (NASDAQ:SRRK) - Seeking Alpha
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Purchases 455,753 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Will Analyst Attention on SRRK Spotlight the Strategic Risks in Scholar Rock’s FDA Response Plan? - simplywall.st
Scholar Rock Holding's Srinivas Akkaraju Acquires 3,707% More Stock - Yahoo Finance
Scholar Rock jumps following Regeneron Eylea update - MSN
Bank of America Begins Coverage on Scholar Rock (NASDAQ:SRRK) - MarketBeat
What MACD and RSI say about Scholar Rock Holding CorporationTrade Signal Summary & Expert Approved Momentum Ideas - newser.com
Why Scholar Rock (SRRK) Stock is Gaining Today - GuruFocus
BofA Securities initiates coverage on Scholar Rock stock with Buy rating - Investing.com Nigeria
B of A Securities Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation - Nasdaq
This Oracle Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
B of A Securities Initiates Coverage on SRRK with a Buy Rating | - GuruFocus
Why Scholar Rock Holding Corporation (2QK) stock stays on top picksJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Scholar Rock (NASDAQ:SRRK) - MarketBeat
Visualizing Scholar Rock Holding Corporation stock with heatmapsJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer - Reuters
Insider Stock Purchases: October 08, 2025 - Quiver Quantitative
Scholar Rock Holding Corporation Stock (SRRK) Opinions on Insider Purchase and FDA Delay - Quiver Quantitative
Wednesday’s Insider Activity: Top Buys and Sells from Tuesday Trading By Investing.com - Investing.com Nigeria
Srinivas Akkaraju Acquires 113,025 Shares of Scholar Rock (NASDAQ:SRRK) Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) Director Purchases $14,438,919.78 in Stock - MarketBeat
Scholar Rock (SRRK) director Akkaraju buys shares worth $18.8 million - Investing.com
Scholar Rock Holding Corporation (SRRK) Stock Analysis: Navigating a 20% Potential Upside in Biotech - DirectorsTalk Interviews
A Fresh Look at Scholar Rock (SRRK) Valuation Following FDA Setback for Apitegromab Approval - simplywall.st
Scholar Rock (SRRK): Assessing Valuation Following FDA Setback for Apitegromab Approval - Yahoo Finance
How strong is Scholar Rock Holding Corporation (2QK) stock earnings growth2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Here's How Much You Would Have Made Owning Scholar Rock Holding Stock In The Last 5 Years - Sahm
Historical volatility pattern of Scholar Rock Holding Corporation visualizedMarket Risk Report & Reliable Volume Spike Alerts - newser.com
Scholar Rock Holding Corp Azioni (SRRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Scholar Rock Holding Corp Azioni (SRRK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director |
Oct 06 '25 |
Buy |
38.65 |
113,025 |
4,368,808 |
500,439 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER |
Sep 22 '25 |
Sale |
30.67 |
3,353 |
102,846 |
108,964 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):